NATHBIOGEN152.50

Nath Bio-Genes (India) Limited

· FMCG & Retail
₹ CrorePeersSARVESHWARINDOUSSUKHJITSKOHINOORAGRITECHREGAALBSHSLGULPOLYMcap ₹290 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity6.505.996.126.12
Return on Assets4.503.763.793.79
Return on Capital Employed7.546.966.906.90
Return on Invested Capital6.966.455.875.43
Margins
EBITDA Margin14.9913.6511.7810.07
Operating Margin14.0112.6010.8910.89
Incremental Operating Margin-1.923.11
Pretax Margin12.5011.1210.408.86
Net Income Margin11.9110.589.357.47
FCF Margin18.612.65-3.50-3.50
Additional
Effective Tax Rate4.684.8910.0910.91
Dvd Payout Ratio9.599.859.13
Sustainable Growth Rate5.885.405.566.12
Incremental Operating Margin %-1.923.11-7.08
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.